106 related articles for article (PubMed ID: 10616519)
1. Tacrolimus toxicity in rhesus monkey: model for clinical side effects.
Kindt MV; Kemp R; Allen HL; Jensen RD; Patrick DH
Transplant Proc; 1999 Dec; 31(8):3393-6. PubMed ID: 10616519
[No Abstract] [Full Text] [Related]
2. Pancreatic islet cell necrosis: association with hemolytic-uremic syndrome.
Burns JC; Berman ER; Fagre JL; Shikes RH; Lum GM
J Pediatr; 1982 Apr; 100(4):582-4. PubMed ID: 7038078
[No Abstract] [Full Text] [Related]
3. Post-renal transplant hemolytic uremic syndrome following combination therapy with tacrolimus and everolimus.
Pratap B; Abraham G; Srinivas CN; Bhaskar S
Saudi J Kidney Dis Transpl; 2007 Nov; 18(4):609-12. PubMed ID: 17951952
[TBL] [Abstract][Full Text] [Related]
4. Tacrolimus-induced hemolytic uremic syndrome and end-stage renal failure after liver transplantation.
Rerolle JP; Akposso K; Lerolle N; Mougenot B; Ponnelle T; Rondeau E; Sraer JD
Clin Transplant; 2000 Jun; 14(3):262-5. PubMed ID: 10831087
[TBL] [Abstract][Full Text] [Related]
5. Necrosis of the pancreas in the haemolytic uraemic syndrome.
Primhak RA; Taitz LS; Variend S; Webb DH; Cser A
J Clin Pathol; 1984 Jun; 37(6):655-8. PubMed ID: 6373838
[TBL] [Abstract][Full Text] [Related]
6. [De novo hemolytic uremic syndrome in a kidney-pancreas recipient in the postoperative period].
Gutiérrez de la Fuente C; Sola E; Alférez MJ; Navarro A; Cabello M; Burgos D; González Molina M
Nefrologia; 2004; 24 Suppl 3():3-6. PubMed ID: 15219059
[TBL] [Abstract][Full Text] [Related]
7. Tacrolimus-induced hemolytic uremic syndrome case presentation in a lung transplant recipient.
Shitrit D; Starobin D; Aravot D; Fink G; Izbicki G; Kramer M
Transplant Proc; 2003 Mar; 35(2):627-8. PubMed ID: 12644073
[No Abstract] [Full Text] [Related]
8. Tacrolimus (FK 506)-induced hemolytic uremic syndrome after heart transplantation.
Walder B; Ricou B; Suter PM
J Heart Lung Transplant; 1998 Oct; 17(10):1004-6. PubMed ID: 9811409
[TBL] [Abstract][Full Text] [Related]
9. Toxicology of FK506 in the cynomolgus monkey: a clinical, biochemical, and histopathological study.
Wijnen RM; Ericzon BG; Tiebosch AT; Buurman WA; Groth CG; Kootstra G
Transpl Int; 1992; 5 Suppl 1():S454-8. PubMed ID: 14621844
[TBL] [Abstract][Full Text] [Related]
10. Rescue treatment for cyclosporine-associated hemolytic-uremic syndrome with intravenous immunoglobulin.
Wen YK; Chen ML
Clin Nephrol; 2006 Jul; 66(1):58-62. PubMed ID: 16878437
[TBL] [Abstract][Full Text] [Related]
11. De novo tacrolimus- associated hemolytic uremic syndrome after renal transplantation - case report.
Neto P; Lopes K; Macário F; Alves R; Mota A; Campos M
Nefrologia; 2013 Jan; 33(1):152-4. PubMed ID: 23364650
[No Abstract] [Full Text] [Related]
12. Combined treatment of tacrolimus and everolimus increases oxidative stress by pharmacological interactions.
Piao SG; Lim SW; Doh KC; Jin L; Heo SB; Zheng YF; Bae SK; Chung BH; Li C; Yang CW
Transplantation; 2014 Jul; 98(1):22-8. PubMed ID: 24825522
[TBL] [Abstract][Full Text] [Related]
13. Tacrolimus-induced HUS: an unusual cause of acute renal failure in nephrotic syndrome.
Pandirikkal VB; Jain M; Gulati S
Pediatr Nephrol; 2007 Feb; 22(2):298-300. PubMed ID: 17123120
[TBL] [Abstract][Full Text] [Related]
14. Islet toxicity of FK506 measured in canine autografts.
Ochiai M; Arita S; Nagai T; Sakamoto Y; Smith CV; Shevlin L; Mullen Y
Transplant Proc; 1998 Mar; 30(2):663. PubMed ID: 9532224
[No Abstract] [Full Text] [Related]
15. Tacrolimus-associated hemolytic uremic syndrome in a pediatric heart transplant recipient.
Gray JM; Ameduri RK
Pediatr Transplant; 2016 Sep; 20(6):866-7. PubMed ID: 27371345
[TBL] [Abstract][Full Text] [Related]
16. Morphological and functional changes of islets of Langerhans in FK506-treated rats.
Hirano Y; Fujihira S; Ohara K; Katsuki S; Noguchi H
Transplantation; 1992 Apr; 53(4):889-94. PubMed ID: 1373536
[TBL] [Abstract][Full Text] [Related]
17. Trophic effects of endogenous and exogenous pancreozymin upon the exocrine and endocrine pancreas.
Fujita T; Matsunari Y; Koga Y; Sato K; Hayashi M
Adv Exp Med Biol; 1978; 106():147-50. PubMed ID: 362856
[No Abstract] [Full Text] [Related]
18. Pancreatic and nephrotoxicity of immunomodulator compounds.
Hammond TG; Kind CN
Toxicol Lett; 1995 Dec; 82-83():99-105. PubMed ID: 8597171
[TBL] [Abstract][Full Text] [Related]
19. Cyclosporin conversion to CellCept in a cadaveric renal allograft recipient with hemolytic uremic syndrome.
Said T; al-Mousawi M; Samhan M; Lao M
Transplant Proc; 1999 Dec; 31(8):3295-7. PubMed ID: 10616482
[No Abstract] [Full Text] [Related]
20. Nephrotoxicity of immunosuppressive drugs.
Bennett WM; Burdmann EA; Andoh TF; Houghton DC; Lindsley J; Elzinga LW
Nephrol Dial Transplant; 1994; 9 Suppl 4():141-5. PubMed ID: 7528363
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
